BlackRock Inc. - NAVIDEA BIOPHARMACEUTICALS I ownership

NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVB and the CUSIP is 63937X202. A total of 26 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of NAVIDEA BIOPHARMACEUTICALS I
ValueSharesWeighting
Q3 2023$10,139
-2.4%
113,030
+0.1%
0.00%
Q2 2023$10,389
-64.6%
112,928
+0.0%
0.00%
Q1 2023$29,350
+23.7%
112,884
-0.1%
0.00%
Q4 2022$23,736
-18.2%
113,029
-0.2%
0.00%
Q3 2022$29,000
-65.9%
113,214
-4.2%
0.00%
Q2 2022$85,000
-37.0%
118,214
-31.0%
0.00%
Q1 2022$135,000
-22.4%
171,411
-1.6%
0.00%
Q4 2021$174,000
-41.8%
174,165
+2.0%
0.00%
Q3 2021$299,000
-5.1%
170,823
-0.6%
0.00%
Q2 2021$315,000
+18.9%
171,788
+31.3%
0.00%
Q1 2021$265,000
-5.7%
130,816
+0.3%
0.00%
Q4 2020$281,000
-19.9%
130,380
+0.2%
0.00%
Q3 2020$351,000
-31.6%
130,125
+0.0%
0.00%
Q2 2020$513,000
+428.9%
130,122
+2.9%
0.00%
Q1 2020$97,000
-39.0%
126,421
+0.5%
0.00%
Q4 2019$159,000
+82.8%
125,851
+0.1%
0.00%
Q3 2019$87,000
+10.1%
125,722
+0.3%
0.00%
Q2 2019$79,000125,3090.00%
Other shareholders
NAVIDEA BIOPHARMACEUTICALS I shareholders Q3 2022
NameSharesValueWeighting ↓
Allred Capital Management, LLC 52,926$113,0000.06%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 109,940$236,0000.01%
PATHSTONE FAMILY OFFICE, LLC 10,050$22,0000.00%
Sowell Financial Services LLC 11,190$24,0000.00%
TWO SIGMA INVESTMENTS, LP 101,949$219,0000.00%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 32,822$71,0000.00%
UBS Group AG 816$2,0000.00%
IFP Advisors, Inc 50$00.00%
OSAIC HOLDINGS, INC. 6$00.00%
Jacobi Capital Management LLC 1,000$2,0000.00%
View complete list of NAVIDEA BIOPHARMACEUTICALS I shareholders